logo
Plus   Neg
Share
Email

Accenture Invests In TripleBlind - Quick Facts

Accenture plc (ACN) said Wednesday it has made a strategic investment, through Accenture Ventures, in TripleBlind, a data privacy and virtual clean room solution provider. Terms of the investment were not disclosed.

Kansas City-based TripleBlind, founded in 2019, helps enterprises to share sensitive information with their stakeholders without decrypting the data and also helps them comply with regulatory requirements.

TripleBlind is now part of Accenture Ventures' Project Spotlight, an engagement and investment program.

Project Spotlight offers extensive access to Accenture's deep domain expertise and its enterprise clients, to help emerging technology software startups harness human creativity and deliver on the promise of their technology.

Amazon noted that through the program, TripleBlind will co-innovate with the company at its Innovation Hubs, Labs and Liquid Studios, working with subject matter experts to bring its solutions to market more quickly and effectively.

TripleBlind is the latest addition to the investment portfolio of Accenture Ventures, which is focused on investing in companies that create or apply disruptive enterprise technologies.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Guitar Center Inc., a retailer of musical instruments, lessons, repairs and rentals, has filed for Chapter 11 bankruptcy reorganization, aiming to significantly reduce its debt and continue its business amid ongoing struggles following the coronavirus pandemic. The company, which operates nearly 300 stores across the U.S., expects to complete the process before the end of this year. Amazon is offering new "Spoiler Free" ways to keep gifts a surprise, as well as to track, receive and pick up orders this holiday season. According to the company, the new features would help customers to face the challenge of keeping those special gifts under wraps as many families are opting to stay home amid the coronavirus pandemic. AstraZeneca Plc and Oxford University's coronavirus vaccine candidate AZD1222 is found to be 70 percent effective on average against Covid-19, according to the British pharmaceutical giant. AstraZeneca plans to immediately prepare regulatory submission of the data to worldwide authorities for conditional or early approval. The company will also ask for an Emergency Use Listing from the WHO.
Follow RTT